GeoVax Labs, Inc. (GOVX) › Shareholders' EquityGeoVax Labs, Inc. (GOVX) — Shareholders' EquityAnnual figures by period end, from SEC filings.2001-12-31: -$170.6K2002-12-31: -$639.4K2003-12-31: $872.4K2004-12-31: -$389.5K2005-12-31: -$500.6K2006-12-31: $2.20M2007-12-31: $2.65M2008-12-31: $2.71M2009-12-31: $3.74M2010-12-31: $1.84M2011-12-31: $703.6K2012-12-31: $1.15M2013-12-31: $2.53M2014-12-31: $1.15M2015-12-31: $1.20M2016-12-31: $240.4K2017-12-31: -$321.1K2018-12-31: -$1.02M2019-12-31: -$1.57M2020-12-31: $9.57M2021-12-31: $4.36M2022-12-31: $26.60M2023-12-31: $5.76M2024-12-31: $5.05M2025-12-31: $3.83M$3.83M2001-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31$3.83M-24.2%2026-04-15Balance as of period end2024-12-31$5.05M-12.4%2026-04-15Balance as of period end2023-12-31$5.76M-78.3%2026-04-15Balance as of period end2022-12-31$26.60M+509.9%2025-03-27Balance as of period end2021-12-31$4.36M-54.4%2024-02-29Balance as of period end2020-12-31$9.57M—2023-03-23Balance as of period end2019-12-31-$1.57M—2022-03-09Balance as of period end2018-12-31-$1.02M—2021-03-23Balance as of period end2017-12-31-$321.1K-233.6%2020-03-24Balance as of period end2016-12-31$240.4K-80.0%2019-03-26Balance as of period end2015-12-31$1.20M+5.1%2019-03-26Balance as of period end2014-12-31$1.15M-54.6%2018-03-23Balance as of period end2013-12-31$2.53M+119.6%2017-03-24Balance as of period end2012-12-31$1.15M+63.6%2016-03-16Balance as of period end2011-12-31$703.6K-61.7%2015-03-20Balance as of period end2010-12-31$1.84M-51.0%2014-03-14Balance as of period end2009-12-31$3.74M+38.2%2014-03-14Balance as of period end2008-12-31$2.71M+2.3%2014-03-14Balance as of period end2007-12-31$2.65M+20.2%2014-03-14Balance as of period end2006-12-31$2.20M—2014-03-14Balance as of period end2005-12-31-$500.6K—2014-03-14Balance as of period end2004-12-31-$389.5K-144.6%2014-03-14Balance as of period end2003-12-31$872.4K—2014-03-14Balance as of period end2002-12-31-$639.4K—2014-03-14Balance as of period end2001-12-31-$170.6K—2014-03-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)